Induction chemoimmunotherapy may improve outcomes of chemoradiotherapy in patients with unresectable stage III NSCLC

BackgroundCurrently, the value of induction chemoimmunotherapy before chemoradiotherapy (CRT) in unresectable stage III non-small cell lung cancer (NSCLC) has not been explored. This study was designed to explore the efficacy and safety of induction chemoimmunotherapy in patients with unresectable s...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Song Guan, Shufeng Zhang, Kai Ren, Xingyue Li, Xue Li, Lujun Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Subjects:	chemoradiotherapy induction chemotherapy induction chemoimmunotherapy non-small cell lung cancer prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1289207/full